Logo
Top

  About

Vantris is a biocompatible, non-absorbable, synthetic tissue-bulking agent designed for the treatment of Vesicoureteral Reflux (VUR) in children.

As a hydrogel comprised of stable, highly malleable macroparticles, Vantris is resistant to particle migration.

Vantris has shown 95,4 % success rate at one-year follow up in clinical data, and demonstrated to be effective even in high-grade reflux: 86,66% of cure in Grade IV and 100% in Grade V reflux, with a single injection procedure. It has a long-term bulking effect.

 

  Brochures

  Surgical

 

 Instruction

Contact